First-in-human phase I study of oral S49076, a unique MET/AXL/FGFR inhibitor, in advanced solid tumours

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
First-in-human phase I study of oral S49076, a unique MET/AXL/FGFR inhibitor, in advanced solid tumours
Authors
Keywords
Phase I clinical trial, Tyrosine kinase inhibitor, MET inhibitor, AXL inhibitor, FGFR inhibitor, S49076, Primary cancer, Metastasis
Journal
EUROPEAN JOURNAL OF CANCER
Volume 81, Issue -, Pages 142-150
Publisher
Elsevier BV
Online
2017-07-06
DOI
10.1016/j.ejca.2017.05.007

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.